|
Centralised Procedure
- Abridged applications for human medicinal products in the EU are applications made under Article 10(1) of Directive 2001/83/EC, as amended.
- Abridged applications for veterinary medicinal products in the EU are applications made under Article 13(1) of Directive 2001/82/EC, as amended.
- The Centralised Procedure (CP) is available to use for generic applications The CP gives the Marketing Authorisation Holder (MAH) a Community Authorisation which allows the MAH to market in all MSs of the EU and EEA on one licence/MA.
- The CP is fully electronic and Ivowen Limited has full eCTD capability.
- Ivowen Limited has a wealth of experience in preparing and submitting dossiers using the CP system, for both human and veterinary medicinal products.
- Ivowen Limited can manage all htmlects of the procedure independently or in liaison with your own Regulatory Affairs department.
Contact us for more information. |